Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-12-28 4:53 pm Sale |
2023-12-26 | 13D | Fate Therapeutics, Inc. FATE |
Redmile Group LLC | 15,049,839 14.900% |
-21,257 (-0.14%) |
Filing History |
| 2023-12-26 4:15 pm Purchase |
2023-12-21 | 13D | Shattuck Labs, Inc. STTK |
Redmile Group LLC | 5,664,892 12.000% |
44,978 (+0.80%) |
Filing History |
| 2023-12-22 4:15 pm Purchase |
2023-12-18 | 13G | Neoleukin Therapeutics, Inc. NLTX |
Redmile Group LLC | 1,282,661 9.900% |
1,282,661 (New Position) |
Filing History |
| 2023-11-22 4:16 pm Purchase |
2023-11-20 | 13D | Augmedix, Inc. AUGX |
Redmile Group LLC | 22,092,211 40.700% |
1,845,891 (+9.12%) |
Filing History |
| 2023-11-17 5:15 pm Purchase |
2023-11-09 | 13G | REGENXBIO Inc. RGNX |
Redmile Group LLC | 4,238,312 9.600% |
2,341,089 (+123.40%) |
Filing History |
| 2023-10-16 5:15 pm Purchase |
2023-10-04 | 13G | ALX Oncology Holdings Inc. ALXO |
Redmile Group LLC | 4,991,545 9.600% |
4,991,545 (New Position) |
Filing History |
| 2023-10-12 5:15 pm Purchase |
2023-10-02 | 13G | Immunome, Inc. IMNM |
Redmile Group LLC | 3,879,415 9.100% |
3,879,415 (New Position) |
Filing History |
| 2023-07-27 5:15 pm Sale |
2023-07-17 | 13D | Neoleukin Therapeutics, Inc. NLTX |
Redmile Group LLC | 145,611 6.600% |
-5,917 (-3.90%) |
Filing History |
| 2023-06-28 5:15 pm Purchase |
2023-06-26 | 13D | IGM Biosciences, Inc. IGMS |
Redmile Group LLC | 3,291,092 9.900% |
257,595 (+8.49%) |
Filing History |
| 2023-06-21 5:15 pm Purchase |
2023-06-16 | 13D | MedAvail Holdings, Inc. MDVL |
Redmile Group LLC | 2,490,145 73.100% |
1,306,257 (+110.34%) |
Filing History |
| 2023-06-15 5:15 pm Unchanged |
2023-06-13 | 13D | Augmedix, Inc. AUGX |
Redmile Group LLC | 20,246,320 44.700% |
0 (Unchanged) |
Filing History |
| 2023-06-13 5:15 pm Sale |
2023-06-12 | 13D | IGM Biosciences, Inc. IGMS |
Redmile Group LLC | 3,033,497 10.300% |
-343,593 (-10.17%) |
Filing History |
| 2023-05-04 5:15 pm Unchanged |
2023-05-02 | 13D | Augmedix, Inc. AUGX |
Redmile Group LLC | 20,246,320 44.700% |
0 (Unchanged) |
Filing History |
| 2023-04-21 5:15 pm Purchase |
2023-04-14 | 13D | Augmedix, Inc. AUGX |
Redmile Group LLC | 20,246,320 44.700% |
4,375,195 (+27.57%) |
Filing History |
| 2023-04-19 5:15 pm Purchase |
2023-04-13 | 13D | Fate Therapeutics, Inc. FATE |
Redmile Group LLC | 15,071,096 14.900% |
2,077,208 (+15.99%) |
Filing History |
| 2023-03-14 5:32 pm Purchase |
2023-03-09 | 13D | MedAvail Holdings, Inc. MDVL |
Redmile Group LLC | 1,183,888 56.500% |
250,405 (+26.82%) |
Filing History |
| 2023-02-14 4:32 pm Sale |
2022-12-31 | 13G | Stereotaxis, Inc. STXS |
Redmile Group LLC | 7,097,616 8.800% |
-210,709 (-2.88%) |
Filing History |
| 2023-02-14 4:32 pm Sale |
2022-12-31 | 13G | Scholar Rock Holding Corporation SRRK |
Redmile Group LLC | 5,501,389 9.900% |
-29,611 (-0.54%) |
Filing History |
| 2023-02-14 4:31 pm Purchase |
2022-12-31 | 13G | HOOKIPA Pharma Inc. HOOK |
Redmile Group LLC | 546,077 9.900% |
268,863 (+96.99%) |
Filing History |
| 2023-02-14 4:29 pm Sale |
2022-12-31 | 13G | Achilles Therapeutics plc ACHL |
Redmile Group LLC | 1,608,089 3.900% |
-480,000 (-22.99%) |
Filing History |